| 吉非替尼治疗晚期非小细胞肺癌疗效分析 |
| |
| 引用本文： | 张进川,李洪霞,张东,安莉. 吉非替尼治疗晚期非小细胞肺癌疗效分析[J]. 中国临床保健杂志, 2007, 10(6): 563-565 |
| |
| 作者姓名： | 张进川 李洪霞 张东 安莉 |
| |
| 作者单位： | 解放军总医院南楼呼吸科,北京,100853;解放军总医院南楼呼吸科,北京,100853;解放军总医院南楼呼吸科,北京,100853;解放军总医院南楼呼吸科,北京,100853 |
| |
| 摘 要： | 目的观察吉非替尼对晚期非小细胞肺癌患者的疗效。方法对吉非替尼治疗的非小细胞肺癌22例进行分析。结果22例中可评估的14例中(5例疾病稳定,2例完全缓解,1例部分缓解)有效率21.4%,临床获益率8/14(57.2%)。结论吉非替尼对晚期非小细胞肺癌疗效较好,其副反应相对小,耐受性好。
|
| 关 键 词： | 癌 非小细胞肺 肿瘤治疗方案 |
| 文章编号： | 1672-6790（2007）06-0563-03 |
| 修稿时间： | 2007-05-15 |
The efficacy of gefitinib in treating non-small cell lung cancer |
| |
| ZHANG Jinchuan,LI Hongxia,ZHANG Dong,AN Li. The efficacy of gefitinib in treating non-small cell lung cancer[J]. Chinese Journal of Clinical Healthcare, 2007, 10(6): 563-565 |
| |
| Authors: | ZHANG Jinchuan LI Hongxia ZHANG Dong AN Li |
| |
| Affiliation: | Department of Respiratory Medicine of Geriatrics, General Hospital of PLA ,Beijing 100853, China |
| |
| Abstract: | Objective To study the efficacy of Gefitinib(Iressa) in treating elderly patients with advanced non-small cell lung cancer.Methods 22 elderly patients with advanced non-small cell lung cancer treated by Gfitinib from Apr 2004 to Dem 2006 with Gfitinib were analyzed.Results Among 14 patients appreciable from all 22 patients,complete response(CR) in 2 cases,partial response(PR) in 1case,stable disease(SD) in 5 cases,so the clinical benefit response(2 1 5)rate was 57.2% and the tumor response(2 1) rate was 21.4%.Conclusion Gefitinib is an effective orally drug in the treatment of patients with non-small cell lung cancer.The of toxicity with Gefitinib is lower and can be well acceptable. |
| |
| Keywords: | Carcinima non-small-cell lung Antineoplastic protocols |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
